Nilo Azad
Impact in
- Oncology top 5%
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Oncology 4
- Colorectal Cancer Treatments and Studies 1
- CAR-T cell therapy research 1
- COVID-19 and healthcare impacts 1
-
- Cancer Genomics and Diagnostics 2
- Co-authors
- Ming‐Tseh Lin (1 shared paper)Gang Zheng (1 shared paper)Li‐Hui Tseng (1 shared paper)Peng Zhang (1 shared paper)Hua Ling (1 shared paper)Christopher D. Gocke (1 shared paper)Elizabeth Anne Montgomery (1 shared paper)James R. Eshleman (1 shared paper)
- Journals
- Human Pathology (1 paper)Journal of Neuro-Oncology (1 paper)Cell Reports Methods (1 paper)Cancer Letters (1 paper)The Lancet (1 paper)
- Partner nations
- United StatesTaiwan
In The Last Decade
Nilo Azad
5 papers receiving 1.3k citations
Nilo Azad's Hit Papers
Peers
Comparison fields: 5 of 73
- Oncology 960
- Infectious Diseases 433
- Obstetrics and Gynecology 44
- General Health Professions 110
- Health 33
Countries citing papers authored by Nilo Azad
This map shows the geographic impact of Nilo Azad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nilo Azad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nilo Azad more than expected).
Fields of papers citing papers by Nilo Azad
This network shows the impact of papers produced by Nilo Azad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nilo Azad. The network helps show where Nilo Azad may publish in the future.
Co-authors
The 25 scholars most cited alongside Nilo Azad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study Hit paper breakdown → | 2020 | 1331 |
| 2 | 2020 | 11 | |
| 3 | 2020 | 5 | |
| 4 | 2025 | 1 | |
| 5 | 2023 | 1 |
About Nilo Azad
Nilo Azad is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Immunology and Pulmonary and Respiratory Medicine, having authored 5 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (2 papers), Colorectal Cancer Treatments and Studies (1 paper), CAR-T cell therapy research (1 paper), COVID-19 and healthcare impacts (1 paper), Epigenetics and DNA Methylation (1 paper), Genetic factors in colorectal cancer (1 paper), Brain Metastases and Treatment (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Oncology (960 citations), Infectious Diseases (433 citations), Obstetrics and Gynecology (44 citations), General Health Professions (110 citations) and Health (33 citations). Nilo Azad has collaborated with scholars based in United States and Taiwan. Frequent co-authors include Ming‐Tseh Lin, Gang Zheng, Li‐Hui Tseng, Peng Zhang, Hua Ling, Christopher D. Gocke, Elizabeth Anne Montgomery, James R. Eshleman, Janelle Marie Montagne and Neeha Zaidi. Their work appears in journals such as Human Pathology, Journal of Neuro-Oncology, Cell Reports Methods, Cancer Letters and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.